--- title: Buy Dolutegravir 50mg Pills Online description: Dolutegravir 50mg is an antiretroviral medication for HIV treatment. Order this essential therapy from our trusted online pharmacy. type: product language: en url: https://liabilis.com/order-dolutegravir-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 131.09 price_max: 348.64 currency: USD offers: - name: 50mg x 30 pills price: 131.09 - name: 50mg x 60 pills price: 208.99 - name: 50mg x 90 pills price: 288.99 - name: 50mg x 120 pills price: 348.64 --- # Buy Dolutegravir 50mg Pills Online Dolutegravir is an integrase inhibitor antiretroviral medication used in combination therapy for HIV treatment. It works by blocking the integration of viral DNA into human DNA, effectively preventing HIV replication. This medication is a crucial component of modern HIV management regimens for adults living with the virus. Our pharmacy offers reliable access to Dolutegravir in 50mg pill form as part of comprehensive treatment support. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **50mg** | 30 pills | **$131.09** | $4.37 | In Stock | | **50mg** | 60 pills | **$208.99** | $3.49 | In Stock | | **50mg** | 90 pills | **$288.99** | $3.21 | In Stock | | **50mg** | 120 pills | **$348.64** | $2.91 | In Stock | [Buy Now](https://liabilis.com/order-dolutegravir-online-en.html) ## Introduction Dolutegravir is a potent antiretroviral medication used to treat human immunodeficiency virus type 1 (HIV-1) infection. It belongs to the class of integrase strand transfer inhibitors (INSTIs) and is supplied as a 50 mg oral tablet. As a generic product, Dolutegravir provides the same therapeutic effect as branded formulations while offering a lower-cost option for patients worldwide. The drug is primarily indicated for use in combination with other antiretrovirals as part of a complete HIV treatment regimen. ## Quick Reference Facts **Active Ingredient** : Dolutegravir **Form** : pill 50 mg **Primary Uses** : Treatment of HIV-1 infection in adults (and children ≥35 kg) when used with nucleoside reverse-transcriptase inhibitors (NRTIs) or as part of fixed-dose combination products. ## What is Dolutegravir? Dolutegravir is the generic version of medications that contain the active compound dolutegravir. It is classified as an integrase strand transfer inhibitor, a subclass of antiretroviral agents that block a critical step in the HIV replication cycle. The drug is marketed under brand names such as Tivicay and is also incorporated into fixed-dose combinations like Triumeq and Dovato. Because it is a generic product, Dolutegravir is bioequivalent to its branded counterparts, delivering identical plasma concentrations and clinical outcomes at a reduced price. The formulation is a single-entity tablet intended for oral administration once daily, with or without food. ## How Dolutegravir Works Dolutegravir targets the HIV-1 integrase enzyme, which catalyzes the insertion of viral DNA into the host cell genome-a step essential for productive infection. By binding to the catalytic core of integrase, dolutegravir prevents the cleavage and joining of viral DNA ends, thereby halting integration. This blockade stops the formation of proviral DNA, effectively stopping the virus from establishing a permanent foothold within infected cells. Pharmacokinetically, dolutegravir is rapidly absorbed, reaching peak plasma concentrations within 2-3 hours after ingestion. It exhibits a high degree of protein binding (~99 %) and is primarily metabolized by the liver enzyme UGT1A1, with minor contributions from CYP3A4. The terminal half-life is approximately 14 hours, supporting once-daily dosing. Renal excretion accounts for less than 1 % of the dose, making dose adjustment unnecessary in most patients with mild to moderate kidney impairment. The drug’s high barrier to resistance and favorable safety profile contribute to its widespread use in first-line HIV therapy. ## Conditions Treated with Dolutegravir - **HIV-1 infection (adults)** - Dolutegravir, combined with two NRTIs, achieves rapid viral suppression and sustained immune recovery. Its high potency allows for effective treatment even in patients with baseline resistance to older INSTIs. - **HIV-1 infection (children ≥35 kg)** - The 50 mg tablet is approved for use in adolescents and children who meet the weight threshold, providing a simplified regimen that aligns with adult dosing. - **Fixed-dose combination therapy** - When co-formulated with agents such as lamivudine and tenofovir alafenamide (e.g., Dovato), dolutegravir supplies the core antiviral activity while reducing pill burden. These indications are based on regulatory approvals from agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The drug’s efficacy stems from its ability to maintain low viral loads, reduce the risk of opportunistic infections, and improve CD4⁺ T-cell counts when adhered to consistently. ## Is Dolutegravir the Right Medication for You? Dolutegravir is most suitable for individuals newly diagnosed with HIV-1 who require a robust, once-daily regimen with a high genetic barrier to resistance. It is also appropriate for patients switching from older regimens, provided there are no contraindicated drug-drug interactions. Patients with documented hypersensitivity to dolutegravir or any tablet excipients should avoid the medication. Caution is advised for those taking antacids containing aluminum, magnesium, calcium, or iron, as these agents can significantly reduce dolutegravir absorption; spacing the doses by at least two hours mitigates this effect. Pregnant women, especially during the first trimester, should discuss potential risks with their healthcare provider. While recent data support the continued use of dolutegravir in pregnancy, a small increase in neural-tube defects has been observed, prompting individualized risk-benefit assessment. Finally, individuals with severe hepatic impairment have not been studied extensively; dose adjustment is not routinely recommended but careful monitoring is warranted. ## Buying Dolutegravir from [our online pharmacy](https://liabilis.com/order-dolutegravir-online-en.html) **Why Choose Our Service?** Access to high-quality antiretroviral therapy can be hindered by cost, supply shortages, or geographic constraints. [our online pharmacy](https://liabilis.com/order-dolutegravir-online-en.html) bridges these gaps, delivering affordable medication directly to your door while preserving your confidentiality. **Quality & Safety Assurance** We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of Dolutegravir is sourced from manufacturers that comply with Good Manufacturing Practice (GMP) standards and is verified by independent quality auditors. **Pricing & Access** Because Dolutegravir is a generic product, we can offer it at a fraction of the price of branded equivalents such as Tivicay. This cost advantage makes long-term HIV management more sustainable for patients and health programmes alike. **Discreet Delivery** Orders are packed in unmarked, tamper-evident packaging and shipped via standard courier services. Most deliveries arrive within 7 days with express options available; standard airmail typically takes up to three weeks. Privacy is guaranteed throughout the fulfillment process. By choosing our pharmacy service, you gain a reliable, affordable, and discreet avenue to obtain the medication you need without compromising safety or efficacy. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** - One 50 mg tablet taken orally once daily, with or without food. - **Missed dose** - If you remember a dose within 12 hours of the scheduled time, take it immediately. If the next dose is due sooner, skip the missed tablet and resume the regular schedule; do not double-dose. - **Overdose** - Symptoms may include dizziness, nausea, or severe headache. Seek immediate medical attention or contact a poison-control center. Supportive care is the mainstay of treatment. **Practical precautions** - - Avoid co-administration of antacids or mineral supplements within two hours of dolutegravir. - Alcohol does not directly affect dolutegravir levels but can exacerbate neurological side effects; moderation is advised. - Do not operate heavy machinery or engage in hazardous activities until you know how the medication affects you, especially during the first few weeks of therapy. ## Safety Information ### ⚠️ Who Should Not Take Dolutegravir - Individuals with a known hypersensitivity to dolutegravir or any tablet component. - Patients receiving concomitant therapy with dofetilide or other drugs that markedly increase dolutegravir plasma concentrations (e.g., strong UGT1A1 inhibitors) should avoid co-administration unless closely monitored. ### Common Side Effects - **Insomnia** - Reported in up to 15 % of patients; usually mild and transient. - **Headache** - Frequently observed during the first weeks of treatment; often resolves without intervention. - **Nausea and abdominal discomfort** - Generally mild; taking the tablet with food can reduce gastrointestinal upset. ### Serious Side Effects (Seek Immediate Medical Help) - **Severe allergic reactions** - Signs include swelling of the face, lips, tongue, or throat, and difficulty breathing. - **Liver toxicity** - Elevated transaminases, jaundice, or hepatic pain require prompt evaluation. - **Neuropsychiatric events** - Rare cases of depression, suicidal ideation, or severe anxiety have been reported; discontinue and seek urgent care if they occur. ### Drug & Food Interactions - **Antacids containing aluminum, magnesium, calcium, or iron** - Reduce dolutegravir absorption; separate dosing by at least two hours. - **Metformin** - Dolutegravir can increase metformin plasma levels; monitor for lactic acidosis symptoms and consider dose adjustment. - **Rifampin (a potent UGT1A1 inducer)** - Lowers dolutegravir concentrations; a twice-daily dosing regimen may be required under specialist guidance. Other medications metabolized by UGT1A1 or CYP3A4 may require dose adjustments or clinical monitoring. Always discuss all concurrent medicines, including over-the-counter products and supplements, with a pharmacist or healthcare professional. ## Off-Label and Investigational Uses of Dolutegravir Dolutegravir has been explored for the treatment of HIV-2 infection, although it is not formally approved for this indication. Small-scale studies indicate comparable antiviral activity to that seen against HIV-1, but larger trials are needed to confirm efficacy and safety. In the realm of pre-exposure prophylaxis (PrEP), investigational protocols have evaluated dolutegravir-based regimens for high-risk populations; early data suggest promising pharmacokinetic profiles, yet definitive efficacy data remain pending. Other off-label investigations include the use of dolutegravir as a latency-reversing agent in “kick-and-kill” strategies aiming to eradicate dormant viral reservoirs. These approaches are still experimental and should only be pursued within controlled clinical trials under expert supervision. Patients should not self-administer dolutegravir for any unapproved purpose without direct oversight from a qualified healthcare provider. ## Storage & Handling - **Temperature** - Store at 20 °C-25 °C (68 °F-77 °F). Protect from extreme heat or freezing. - **Moisture** - Keep tablets in the original blister pack until use; moisture can degrade the active ingredient. - **Expiry** - Do not use after the printed expiration date. Dispose of expired tablets according to local regulations. - **Disposal** - When no longer needed, place tablets in a sealed container and discard with household waste, unless a medication take-back program is available. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Dolutegravir?** Yes. Carry the medication in its original packaging with a copy of your prescription or a physician’s letter, as some countries require documentation for antiretrovirals. - **Should I avoid any specific foods while taking Dolutegravir?** No major dietary restrictions exist, but calcium-rich foods or supplements should be spaced at least two hours apart from the dose to prevent absorption interference. - **Is it safe to drink alcohol while on Dolutegravir?** Moderate alcohol consumption does not affect dolutegravir levels, but excessive intake may worsen side effects such as dizziness or insomnia. **Product & Formulation Details** - **What do Dolutegravir tablets look like?** The generic 50 mg tablet is typically white, round, and uncoated, though appearance may vary slightly between manufacturers. - **Can I split or crush a Dolutegravir tablet?** Splitting is not recommended because it can result in uneven dosing; crushing is generally unnecessary as the tablet is formulated for oral absorption without need for alteration. **Regulatory & Safety Nuances** - **Will Dolutegravir show up on standard drug tests?** Dolutegravir is not screened for in routine occupational or sports drug tests, as it is not a prohibited performance-enhancing substance. - **Are there special import rules for Dolutegravir in my country?** Import regulations vary; many jurisdictions allow personal import of a 90-day supply for personal use, provided a valid prescription is presented. Check local customs guidelines before ordering. **Scientific & Clinical Curiosity** - **What were the key clinical trials that led to Dolutegravir approval?** Pivotal studies such as SPRING-2, SINGLE, and FLAMINGO demonstrated superior viral suppression rates and favorable safety profiles compared with efavirenz- or raltegravir-based regimens. - **How does Dolutegravir compare with older INSTIs like raltegravir?** Dolutegravir has a higher genetic barrier to resistance and requires once-daily dosing, whereas raltegravir is dosed twice daily and has a lower barrier, making dolutegravir preferable for many treatment-naïve patients. ## Glossary **Integrase Strand Transfer Inhibitor (INSTI)** : A class of antiretroviral drugs that block the HIV integrase enzyme, preventing viral DNA from integrating into the host genome. **Bioequivalence** : The property whereby a generic drug delivers the same amount of active ingredient into a patient’s bloodstream as the branded reference product, under similar conditions. **UGT1A1** : An enzyme in the liver responsible for glucuronidation, a major metabolic pathway for dolutegravir. **Genetic Barrier to Resistance** : A measure of how easily a virus can develop mutations that diminish a drug’s effectiveness; a high barrier means resistance is less likely to arise. **Pharmacokinetics** : The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body. ## Disclaimer The information provided about **Dolutegravir** is intended for general educational purposes and does not replace professional medical consultation. All therapeutic decisions, including those concerning off-label applications, should be made under the guidance of a qualified healthcare provider. Readers are presumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://liabilis.com/order-dolutegravir-online-en.html) offers access to **Dolutegravir** for individuals who may encounter limited availability through conventional channels, face insurance constraints, or seek cost-effective generic alternatives. Always discuss with your physician before initiating, modifying, or discontinuing any medication.